Unique ID issued by UMIN | UMIN000024641 |
---|---|
Receipt number | R000028347 |
Scientific Title | An Open Study of Sulforaphane-rich Broccoli Sprout Extract in Patients with Schizophrenia |
Date of disclosure of the study information | 2016/10/31 |
Last modified on | 2016/10/31 10:39:04 |
An Open Study of Sulforaphane-rich Broccoli Sprout Extract in Patients with
Schizophrenia
Open study of Sulforaphane for schizophrenia
An Open Study of Sulforaphane-rich Broccoli Sprout Extract in Patients with
Schizophrenia
Open study of Sulforaphane for schizophrenia
Japan |
Schizophrenia
Psychiatry |
Others
NO
To evaluate the effect of sulforaphane in medicated patients with schizophrenia.
Safety,Efficacy
The change of the total score of PANSS between before and after taking sulforaphane
The change of each score of CogState test battery between before and after taking sulforaphane.
The data of blood exams.
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Other |
Participants take 3 tablets of Sulforaphane (SFN), consisting of 30 mg of SFN-glucosinolate per day, for 8 weeks.
20 | years-old | <= |
65 | years-old | > |
Male and Female
Meeting criteria defined by the Diagnostic and Statistical Manual of Mental Disorders 4th ddition test revised.
Outpatients from Chiba University Hospital.
Being prescribed a single atypical antipsychotic drug (aripiprazole, blonanserin, olanzapine, paliperidone, perospirone, quetiapine, or risperidone) at a fixed dose, for at least 4 weeks before study entry.
Not knowing the clnical diagnoses.
Diagnosed with intellectual disabilities, developmental disorders, attention-deficit hyperactivity disorders, delirium, dementia or other types of cognitive impairmentimpairment, substance misuse disorders (except caffeine or nicotine), eating disorders, or personality disorders.
Necessary to take strict diet, or other serious medical conditions.
With a history of taking clozapine.
With a history of taking antipsychotic depot injection, electro-convulsive therapy, or transcutaneous magnetic stimulation therapy within 3 months.
Previously being administered SFN over 8 weeks.
With allergic reaction to some kind of vegetable.
Having extraordinary eating behaviors.
Pregnant women and new mothers.
Having a history of participating other clinical trials within 3 months.
Unstable physical or psychological status.
Having a history of suicide attempt within 1 year.
Any other conditions so that the doctor in charge deny the indication.
10
1st name | |
Middle name | |
Last name | Masaomi Iyo |
Chiba University Graduate School of Medicine
Department of Psychiatry
Inohana, 1-8-1, Chuoh-ku, Chiba-shi, Chiba
043-222-7171
iyom@faculty.chiba-u.jp
1st name | |
Middle name | |
Last name | Akihiro Shiina |
Chiba University Center for Forensic Mental Health
Division of Medical Treatment and Rehabilitation
Inohana, 1-8-1, Chuoh-ku, Chiba-shi, Chiba
043-222-7171
shiina-akihiro@faculty.chiba-u.jp
Chiba University
Chiba University
Other
YES
NCT01716858
the U.S. National Institutes of Health
千葉大学医学部附属病院(千葉県)
2016 | Year | 10 | Month | 31 | Day |
Published
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4423155/
A total of 7 patients completed the trial. The mean score in the Accuracy component of the One Card Learning Task increased significantly after the trial. However, we detected no other significant changes in participants.
Completed
2012 | Year | 08 | Month | 29 | Day |
2012 | Year | 10 | Month | 26 | Day |
2013 | Year | 06 | Month | 14 | Day |
2013 | Year | 06 | Month | 14 | Day |
2013 | Year | 06 | Month | 14 | Day |
2013 | Year | 12 | Month | 01 | Day |
2016 | Year | 10 | Month | 31 | Day |
2016 | Year | 10 | Month | 31 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000028347
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |